Artelo Biosciences (ARTL) News Today → America could fall from this event (From Porter & Company) (Ad) Free ARTL Stock Alerts $1.30 -0.04 (-2.99%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13 at 8:07 AM | finance.yahoo.comArtelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 13 at 8:00 AM | globenewswire.comArtelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 10, 2024 | globenewswire.comArtelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14thApril 23, 2024 | globenewswire.comArtelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer TherapyApril 22, 2024 | globenewswire.comArtelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern TimeMarch 25, 2024 | benzinga.comRecap: Artelo Biosciences Q4 EarningsMarch 25, 2024 | msn.comArtelo Biosciences GAAP EPS of -$3.14 misses by $0.58March 25, 2024 | globenewswire.comArtelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business UpdateMarch 12, 2024 | globenewswire.comArtelo Biosciences Selected as a Finalist in Johnson & Johnson's Innovation ChallengeFebruary 15, 2024 | finanznachrichten.deArtelo Biosciences, Inc.: Artelo Biosciences to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20thJanuary 8, 2024 | finance.yahoo.comArtelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12December 5, 2023 | finance.yahoo.comArtelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in GermanyNovember 16, 2023 | markets.businessinsider.comPromising Developments in Artelo Biosciences’ Cancer Therapies Drive Buy Rating RecommendationNovember 13, 2023 | msn.comArtelo Biosciences GAAP EPS of -$0.83 misses by $0.18November 13, 2023 | finance.yahoo.comArtelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business UpdateNovember 7, 2023 | morningstar.comArtelo Biosciences Inc ARTLNovember 2, 2023 | finance.yahoo.comArtelo Biosciences to Present Preclinical Data Showcasing Research on ART26.12 and ART12.11 in Anxiety and Depression at Neuroscience 2023September 5, 2023 | finance.yahoo.comArtelo Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 13thAugust 11, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Larimar Therapeutics (LRMR), Artelo Biosciences (ARTL) and Unity Biotechnology (UBX)June 28, 2023 | markets.businessinsider.comArtelo Biosciences (ARTL) Receives a Buy from Ladenburg Thalmann & Co.June 27, 2023 | msn.comArtelo Unvails New Data On ART26.12 Demonstrating Positive Effects In Multiple Models Of Neuropathic PainJune 27, 2023 | finance.yahoo.comArtelo Biosciences Announces Important New Data on ART26.12 Demonstrating Positive Effects in Multiple Models of Neuropathic Pain at the 33rd Annual International Cannabinoid Research Society SymposiumMay 18, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Artelo Biosciences (ARTL), Iterum Therapeutics (ITRM) and TScan Therapeutics (TCRX)May 11, 2023 | msn.comArtelo Biosciences: Q1 Earnings InsightsMay 11, 2023 | finance.yahoo.comArtelo Biosciences Reports First Quarter 2023 Financial Results and Provides Business UpdateApril 25, 2023 | finance.yahoo.comArtelo Biosciences Initiates the Phase 2a Portion of its CAReS Trial EvaluatingART27.13 for the Treatment of Cancer-Related Anorexia and Weight LossApril 4, 2023 | markets.businessinsider.comArtelo Biosciences (ARTL) Gets a Buy from Maxim GroupApril 3, 2023 | markets.businessinsider.comArtelo Biosciences (ARTL) Gets a Buy from Ladenburg Thalmann & Co.April 2, 2023 | seekingalpha.comArtelo Biosciences GAAP EPS of -$3.56February 15, 2023 | finance.yahoo.comArtelo Biosciences to Present at MicroCap Rodeo’s Annual Winter Wonderland – Best Ideas Virtual Investor Conference on February 22, 2023November 8, 2022 | finance.yahoo.comArtelo Biosciences Reports Third Quarter 2022 Financial Results and Provides Business UpdateOctober 18, 2022 | finance.yahoo.comArtelo Biosciences to Present at The LD Micro Main Event XVOctober 11, 2022 | seekingalpha.comARTL Artelo Biosciences, Inc.September 22, 2022 | finance.yahoo.comArtelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29thSeptember 7, 2022 | finance.yahoo.comArtelo Biosciences to Present at the H.C. Wainwright 24th Annual Global Investment ConferenceAugust 17, 2022 | morningstar.comThinking about buying stock in Bed Bath & Beyond, Chembio Diagnostics, Giga Media, Artelo Biosciences, or SNDL?August 17, 2022 | msn.comU.S. Stocks Open Lower; Nasdaq Down 150 PointsAugust 16, 2022 | markets.businessinsider.comNasdaq Falls 75 Points; Ventyx Biosciences Shares Spike HigherAugust 16, 2022 | seekingalpha.comArtelo jumps 21% as publication highlights pre-clinical data on drug platformAugust 16, 2022 | finance.yahoo.comArtelo Biosciences Reports Positive Pre-Clinical Results with its Novel Inhibitor to Fatty Acid Binding Protein 5August 12, 2022 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Artelo Biosciences (NASDAQ:ARTL)HC Wainwright reaffirmed a "buy" rating and set a $55.00 target price on shares of Artelo Biosciences in a research note on Friday.August 10, 2022 | marketbeat.comTrading was temporarily halted for "ARTL" at 03:08 PM with a stated reason of "LULD pause."August 10, 2022 | marketbeat.comTrading was temporarily halted for "ARTL" at 03:08 PM with a stated reason of "LULD pause."August 10, 2022 | marketbeat.comTrading was temporarily halted for "ARTL" at 02:08 PM with a stated reason of "LULD pause."August 6, 2022 | finance.yahoo.comArtelo Biosciences, Inc. (ARTL)June 27, 2022 | msn.comArtelo Biosciences Reveals Positive Pre-Clinical Results Of ART26.12, A Novel FABP5 Inhibitor, In Alleviating Chemotherapy-Induced PainJune 27, 2022 | finance.yahoo.comArtelo Biosciences Presents Positive Pre-Clinical Results of ART26.12, a Novel FABP5 Inhibitor, in Alleviating Chemotherapy-Induced PainJune 24, 2022 | finance.yahoo.comArtelo Biosciences Selected for Oral Presentation at the 32nd Annual ICRS Symposium in Galway, IrelandJune 3, 2022 | morningstar.comArtelo Biosciences Inc - Stock NewsMay 14, 2022 | finanznachrichten.deArtelo Biosciences, Inc.: Artelo Biosciences to Present at MicroCap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16th Get Artelo Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ARTL and its competitors with MarketBeat's FREE daily newsletter. Email Address Guard Against the Coming Financial Upheaval (Ad)America’s Most Shocking Financial Story… Behind closed doors in D.C., there is a dark political and economic plot underway. That’s why if you have any savings in the bank or own any assets you want to protect, you must watch this new documentary before it’s too late. You can stream it for free right here. ARTL Media Mentions By Week ARTL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARTL News Sentiment▼0.800.57▲Average Medical News Sentiment ARTL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARTL Articles This Week▼60▲ARTL Articles Average Week Get Artelo Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ARTL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Ensysce Biosciences News Longeveron News Soligenix News Exicure News Tharimmune News Evoke Pharma News Revelation Biosciences News GT Biopharma News Alzamend Neuro News Phio Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARTL) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersGuard Against the Coming Financial UpheavalPorter & CompanyElon’s New Device is About to Shock the WorldInvestorPlaceConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
